AFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA).
Published January 25, 2017 · Recall initiated: December 27, 2016
Summary
FDA records medical device Class II recall Z-1037-2017, published January 25, 2017 and initiated December 27, 2016. Recalling firm: Endologix; Status: Terminated; Lot: The correction is not lot specific. It applies to AFX procedures conducted after July 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Endologix
- Distributor
- Worldwide Distribution - US (nationwide) and Internationally to Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Luxembourg, Monaco, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, Turkey, and United Kingdom.
- Lot
- The correction is not lot specific. It applies to AFX procedures conducted after July 2015
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft, Rx Only, Sterile EO, AFX Proximal Accessory,October 10, 2018
- FDAAFX Endovascular AAA System, Endoleak Type IIIB Common Name: AFX Bifurcated and Accessory Stent GraftsJanuary 25, 2017
- FDAAFX2 Endovascular AAA System Item No. Item Description F00820-01 BEA28-120/I20-40 F00820-02 BEA28-100/I20-40January 25, 2017
- FDAAFX Endovascular AAA System, Endoleak Type: IIIB Common Name: AFX Bifurcated and Accessory Stent GraftsJanuary 25, 2017
- FDAAFX Endovascular AAA System, Endoleak Type IIIAJanuary 25, 2017
- FDAAFX Endovascular AAA System, Endoleak Type IIIB; The AFX Endovascular AAA System is intended for endovascularJanuary 25, 2017
Questions about this recall
Was AFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA). recalled?
Yes. FDA published recall Z-1037-2017 on January 25, 2017. Reported hazard: Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).
What should I do if I have this product?
Voluntary: Firm initiated · Letter